Skip to main content

Table 3 Association of elevated high-sensitivity troponin I (hs-TnI) with subsequent major adverse cardiovascular events (MACE), heart failure, myocardial infarction and cardiovascular mortality

From: Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus

 

Univariate analysis

Variables

HR

95% CI

P value

MACE

   

 Unadjusteda

5.69

3.05-10.62

<0.01

 Adjusted for demographic factorsb

3.81

2.01-7.24

<0.01

 Adjusted for demographic, cardiovascular risk factorsc

3.70

1.91-7.18

<0.01

 Adjusted for demographic, cardiovascular risk factors and eGFRd

2.85

1.15-7.03

0.02

Heart failure

   

 Unadjusteda

7.21

2.70-19.25

<0.01

 Adjusted for demographic factorsb

4.98

1.80-13.83

<0.01

 Adjusted for demographic, cardiovascular risk factorsc

4.88

1.71-13.96

<0.01

 Adjusted for demographic, cardiovascular risk factors and eGFRd

4.88

1.12-21.31

0.03

Myocardial infarction

   

 Unadjusteda

2.45

0.72-8.31

0.15

 Adjusted for demographic factorsb

1.70

0.48-5.99

0.41

 Adjusted for demographic, cardiovascular risk factorsc

1.34

0.36-5.04

0.67

 Adjusted for demographic, cardiovascular risk factors and eGFRd

0.84

0.12-6.17

0.87

Cardiovascular mortality

   

 Unadjusteda

15.90

3.52-71.87

<0.01

 Adjusted for demographic factorsb

10.0

2.13-47.19

<0.01

 Adjusted for demographic, cardiovascular risk factorsc

9.14

1.92-43.60

<0.01

 Adjusted for demographic, cardiovascular risk factors and eGFRd

6.19

0.50-76.59

0.16

  1. Abbreviations as in Table 1; HR = hazard ratio.
  2. aAll models additionally adjusted for hs-TnI.
  3. bAdjusted for age and gender.
  4. cAdjusted for modelb and hypertension, hyperlipidemia, smoking history and coronary heart disease.
  5. dAdjusted for modelc and eGFR.